Powder: -20°C for 3 years | In solvent: -80°C for 1 year
(±)11,12-DiHETE is a dihydroxy metabolite of EPA produced by cytochrome P450-mediated epoxide formation and subsequent hydrolysis by epoxide hydrolase. Plasma levels of (±)11,12-DiHETE are increased over baseline after an oral dose of 1008 mg EPA.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 μg | 約 35 days | ¥ 60,500 |
50 μg | 約 35 days | ¥ 112,000 |
100 μg | 約 35 days | ¥ 212,000 |
説明 | (±)11,12-DiHETE is a dihydroxy metabolite of EPA produced by cytochrome P450-mediated epoxide formation and subsequent hydrolysis by epoxide hydrolase. Plasma levels of (±)11,12-DiHETE are increased over baseline after an oral dose of 1008 mg EPA. |
分子量 | 336.472 |
分子式 | C20H32O4 |
CAS No. | 867350-92-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 30 mg/mL
DMF: 30 mg/mL
PBS (pH 7.2): 0.5 mg/mL
DMSO: 30 mg/mL
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
(±)11,12-DiHETE 867350-92-3 11,12-DiHETE (±)11,12 DiHETE (±)11,12DiHETE Inhibitor inhibitor inhibit